RadNet earnings slip, volume rises
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008.
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008. For the three months ended Sept. 30, 2009, RadNet reported revenue of $133.4 million versus $130.9 million in 3Q 2008 and a loss of $1.7 million compared with net income of $138,000. On a same-center basis, including only centers that were part of RadNet for both the third quarters of 2009 and 2008, MRI volume increased 5.4%, CT volume increased 4.0%, and PET/CT volume increased 4.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.2% over the same quarter in the prior year.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
